iBio, Inc. (IBIO)

iBio, Inc. Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	7.58	28.67	77.4	55.11	4.42
Short-Term Investments	0	10.85	19.57	0	0
Cash & Cash Equivalents	7.58	39.52	96.97	55.11	4.42
Cash Growth	-80.82%	-59.25%	75.96%	1146.60%	-72.25%
Receivables	0	1	0.43	0.08	0.1
Inventory	0	0	0.03	0.8	0
Other Current Assets	18.68	4.55	7.17	5.76	0.29
Total Current Assets	26.26	45.07	104.6	61.75	4.81
Property, Plant & Equipment	7.55	4.44	34.74	31.27	24.38
Long-Term Investments	1.71	1.63	1.56	0	0
Goodwill and Intangibles	5.39	4.85	0.95	1.14	1.37
Other Long-Term Assets	0.3	43.41	5.12	0.02	0.02
Total Long-Term Assets	14.95	54.34	42.37	32.44	25.78
Total Assets	41.21	99.41	146.97	94.19	30.59
Accounts Payable	1.85	4.26	2.25	1.76	1
Deferred Revenue	0	0.1	0.42	1.81	1.28
Current Debt	13.76	22.25	0.97	0.56	0.21
Other Current Liabilities	5.98	3.82	3	1.11	0.97
Total Current Liabilities	21.58	30.44	6.65	5.24	3.46
Long-Term Debt	3.72	3.51	31.76	32.35	24.67
Other Long-Term Liabilities	0.53	1.97	0	0	0
Total Long-Term Liabilities	4.24	5.49	31.76	32.35	24.67
Total Liabilities	25.83	35.92	38.4	37.58	28.13
Total Debt	17.48	25.77	32.72	32.91	24.88
Debt Growth	-32.18%	-21.26%	-0.57%	32.25%	-0.79%
Retained Earnings	-288.94	-223.93	-173.63	-150.42	-105.82
Comprehensive Income	0	-0.21	-0.06	-0.03	-0.03
Shareholders' Equity	15.38	63.49	108.59	56.62	2.46
Net Cash / Debt	-9.9	13.75	64.25	22.2	-20.46
Net Cash / Debt Growth	-	-78.60%	189.37%	-	-
Net Cash Per Share	-16.16	31.54	164.22	176.80	-540.61
Working Capital	4.68	14.63	97.95	56.51	1.35
Book Value Per Share	25.12	145.59	277.53	450.82	65.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).